PharmaJet touted results today from a study evaluating its needle-free injection technology as a way to administer the poliovirus vaccine.
The company reported that its Tropis device was a more efficient way to give the vaccine compared to a needle and syringe – the average preparation and administration time was up to 70% faster for those using the needle-free device.
PharmaJet added that practitioners using the Tropis device was able to extract an average of 5.3 doses per 5-dose vial, which allowed them to vaccinate 32 more children than expected given the total supply.
Healthcare workers administering the vaccine reported less crying from kids when they used the Tropis system and that the device was easy to use.
“The PharmaJet Tropis simple point and click design is easy-to-use, and ensures consistent and accurate intradermal injection,” chairman & CEO Ron Lowy said in prepared remarks.
“Additionally, the significantly faster preparation and administration time compared to traditional ID technique with a needle and syringe, makes it an ideal choice for vaccination campaigns.”
The company’s device is being used in polio eradication efforts across Cuba, Gambia, Pakistan and Bangladesh, according to PharmaJet.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.